ECSP982620A - DERIVATIVES OF ARILOXIARILSULFONILAMINO HIDROXAMICOS ACIDS - Google Patents

DERIVATIVES OF ARILOXIARILSULFONILAMINO HIDROXAMICOS ACIDS

Info

Publication number
ECSP982620A
ECSP982620A ECSP982620A ECSP982620A EC SP982620 A ECSP982620 A EC SP982620A EC SP982620 A ECSP982620 A EC SP982620A EC SP982620 A ECSP982620 A EC SP982620A
Authority
EC
Ecuador
Prior art keywords
hidroxamicos
ariloxiarilsulfonilamino
derivatives
acids
metalloproteinsa
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Robinson Ralph Pelton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982620 priority Critical patent/ECSP982620A/en
Publication of ECSP982620A publication Critical patent/ECSP982620A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El invento se refiere a: un compuesto de la fórmula (gráfico), en la que X, Y, R1 y R2 son como se define anteriormente, útiles en el tratamiento de artritis o cáncer y otras enfermedades que impliquen la inhibición selectiva de metaloproteinsa-13 de matriz.The invention relates to: a compound of the formula (graph), in which X, Y, R1 and R2 are as defined above, useful in the treatment of arthritis or cancer and other diseases involving the selective inhibition of metalloproteinsa- Matrix 13.

ECSP982620 1998-08-07 1998-08-07 DERIVATIVES OF ARILOXIARILSULFONILAMINO HIDROXAMICOS ACIDS ECSP982620A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982620 ECSP982620A (en) 1998-08-07 1998-08-07 DERIVATIVES OF ARILOXIARILSULFONILAMINO HIDROXAMICOS ACIDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982620 ECSP982620A (en) 1998-08-07 1998-08-07 DERIVATIVES OF ARILOXIARILSULFONILAMINO HIDROXAMICOS ACIDS

Publications (1)

Publication Number Publication Date
ECSP982620A true ECSP982620A (en) 1999-04-13

Family

ID=42043541

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982620 ECSP982620A (en) 1998-08-07 1998-08-07 DERIVATIVES OF ARILOXIARILSULFONILAMINO HIDROXAMICOS ACIDS

Country Status (1)

Country Link
EC (1) ECSP982620A (en)

Similar Documents

Publication Publication Date Title
CO5210911A1 (en) NEMATICIDED TRIFLUORBUTENS
MY142018A (en) Thiophene derivatives as chk 1 inihibitors
BR9710737A (en) Pentafluorobenzenesulfonamides and the like.
UY26285A1 (en) PIRIMIDINE-2,4,6-TRIONAS METALOPROTEINASE INHIBITORS
BR0214035A (en) Compound
PT952148E (en) CYLOBUTIL-ARYLOXYARILSULFONYLAMINO-HYDROXYMIC ACID DERIVATIVES
ECSP034568A (en) PIRIMIDIN 2,4,6-TRIONA TYPE METALOPROTEINASE INHIBITORS
HN2001000244A (en) SPIROPIRIMIDIN INHIBITORS - 2, 4, 6 - TRIONA METALOPROTEINASAS.
GT199900140A (en) DERIVATIVES OF QUINOLIN-2-ONA ALQUINILS SUBSTITUTED USEFUL AS ANTI-TARGET AGENTS.
PA8444201A1 (en) CYCLE DERIVATIVES OF SULFONA
MX9804588A (en) Use of halogen bleach-comprising compositions for improved mildness to the skin.
AR029214A1 (en) PHOSPHODIESTERASE INHIBITING COMPOUNDS - 4: 8 - SUBSTITUTED ARILQUINOLINS, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHOD USING THEM
ES2150705T3 (en) USEFUL STEROID NITRITE ESTER DERIVATIVES AS ANTI-INFLAMMATORY PHARMACES.
ES2151168T3 (en) N- (2,4-DIOXO-2,3,4,5-TETRAHYDRO-1H-1,5-BENZODIAZEPIN-3-IL) -3-AMIDAS.
PA8571501A1 (en) INHIBITORS TRIARILOXIARILOXIPIRIMIDIN-2,4,6-METALOPROTEINASE TRION
BRPI0415678A (en) pyrimidine compounds for treating inflammation
SE9801494D0 (en) Novel use
UY27250A1 (en) PHENYL-HETEROCICLIL-CTERES
ES2060127T3 (en) HALOGENOALKYLPHENYL-ALCOHOLS-KETONES AND THEIR HYDRATES.
ATE246708T1 (en) ELATASE INHIBITORS
ES2142490T3 (en) CYCLOPEPTOLIDS.
BR0315489A (en) Antitumor Composition
DE69911017D1 (en) Arylsulfonanilid-phosphate
ECSP982620A (en) DERIVATIVES OF ARILOXIARILSULFONILAMINO HIDROXAMICOS ACIDS
ES2108004T3 (en) NEW RENTAL PIPERIDINES SUBSTITUTED AND THEIR USE AS INHIBITORS OF CHOLESTEROL SYNTHESIS.